- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 890
Katerra begins constructing $700m round
The building services provider is lining up a $700m round that looks set to be led by SoftBank Vision Fund, valuing it at more than $4bn.
Jan 15, 2019Macnica makes $40m investment in CrowdAnalytix
Macnica has purchased a 41.8% stake in the AI crowdsourcing platform through a primary and secondary share deal having been a partner since late 2017.
Jan 15, 2019Yimi Dida collects $266m
Prologis invested in logistics and delivery service Shanghai Yimi Dida in a series D round that will go to R&D and the expansion of its transport options.
Jan 15, 2019Emeritus retains Bertelsmann in $40m series C
The online education provider will add blockchain and cybersecurity courses to its roster following the Bertelsmann India Investments-backed round.
Jan 15, 2019WeWork turns gold to Laird in $32m round
The workspace operator invested in a round that will support superfood supplier Laird's product development and acquisitions.
Jan 15, 2019Mitsui helps Napajen nab series C funding
P&E Directions has joined existing investor Mitsui in a $12.4m round that increased the immunotherapy developer's total funding to more than $37m.
Jan 15, 2019B2Link connects to corporates to secure $15m
Cosmetics e-commerce platform and services provider B2Link has reeled in $15m in a round backed by Posco Capital and Kolmar Korea.
Jan 15, 2019Repsol wraps up Nanogap investment
Nanomaterials provider Nanogap, a spinout of University of Santiago de Compostela, received $2.1m from Repsol's Corporate Venture vehicle.
Jan 14, 2019SenseTime tenses for $2bn round
The artificial intelligence software provider, which counts Alibaba, Qualcomm, Suning and Dalian Wanda as investors, is looking to raise about $2bn in funding.
Jan 14, 2019Investors deliver $2.5m to AmacaThera
Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.
Jan 14, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


